Governance

The team and organisations behind IRONMAN

IRONMAN is governed by an Executive Committee, a Scientific Advisory Committee and the Global Clinical & Data Coordination Center (CDCC), and have also established a Diversity Working Group.

About the Executive Committee 

The Executive Committee independently governs the project direction, clinical and financial management, and also ensures the objectives and vision of the IRONMAN Registry are met. Registry reports and publications will be managed by the Executive Committee with input from the Scientific Advisory Committee. 

Associate Professor Lorelei Mucci

Associate Professor of Epidemiology

Harvard TH Chan School of Public Health

Dr. Daniel George

Professor of Medicine, Director of Genitourinary Oncology

Duke Cancer Institute

Dr. Philip Kantoff

Chairman of Medicine

Memorial Sloan Kettering Cancer Center

Jake Vinson

Chief Executive Officer

Prostate Cancer Clinical Trials Consortium

Paul Villanti

Executive Director, Programs

Movember Foundation

About the Scientific Advisory Committee

The Scientific Advisory Committee will consist of representatives from country lead participating sites, Funding Companies (non-voting members) and the advocacy community. They will evaluate the accumulated study data and make recommendations to Executive Committee concerning the IRONMAN Registry.

Professor Ian Davis

Professor of Medicine

Monash University and Eastern Health

Associate Professor Sue Evans

Head of Clinical Registry Unit

Monash University

Professor Andre Fay

Professor of Medicine

Pontifícia Universidade Católica do Rio Grande do Sul

Professor Raymond McDermott

Medical Oncologist

Trinity College, Dublin

Dr Stephen Finn

Pathologist

University of Dublin and Trinity College, Dublin

Professor Anders Bjartell

Medical Professor

Skåne University Hospital, Malmö, Sweden

Professor Ove Andren

Professor of Urology

Orebro University Hospital

Dr Aurelius Omlin

Medical Doctor, Consultant

Kantonsspital, St. Gallen

Professor Silke Gillessen

Professor of Medicine, Consultant

Kantonsspital, St. Gallen

Dr Simon Chowdhury

Consultant Medical Oncologist

Guy’s Hospital

Dr Deborah Enting

Consultant Medical Oncologist

Guy’s Hospital

Dr Daniel George

Professor of Medicine and Director of Genitourinary Oncology

Duke University

Dr Philip Kantoff

Chairman of Medicine

Memorial Sloan Kettering Cancer Center

Dr Lorelei Mucci

Associate Professor of Epidemiology

Harvard TH Chan School of Public Health

Stacey Simmons

Director of Oncology

Bayer

Joseph Germino

Bayer

Richard Davidson

AstraZeneca

Ted Szatrowski

Sanofi

Bruce Brown

Astellas

Global Clinical & Data Coordination Center (CDCC)

The Prostate Cancer Clinical Trials Consortium (PCCTC) is the Global Clinical and Data Coordination Center for the IRONMAN Registry. The PCCTC provides project management, contracting, regulatory supervision, site management in the U.S., data management and quality assurance for the entire Registry, and data monitoring according to this protocol and any individual funding partner agreements. 

Jake Vinson

Chief Executive Officer

Prostate Cancer Clinical Trials Consortium

Adam Friedant

Project Manager

Prostate Cancer Clinical Trials Consortium

Julie Filipenko

Director, Clinical Data Management and Informatics

Prostate Cancer Clinical Trials Consortium

Diversity Working Group

Dr. Franklin Huang

GU Oncologist and co-founder of Global Oncology

Dana Farber Cancer Institute

Dr. Elisabeth Heath

Medical Oncologist, Center Director for Translational Sciences

Karmanos Cancer Institute, Wayne State University

Dr. Daniel George

Professor of Medicine, Director of Genitourinary Oncology

Duke Cancer Institute

Associate Professor Lorelei Mucci

Associate Professor of Epidemiology

Harvard TH Chan School of Public Health

Kellie Paich

TrueNTH Program Lead

Movember Foundation

Assistant Professor Rana McKay

Medical Oncologist, Assistant Professor of Medicine

UCSD Moores Cancer Center

Dr. Jelani Zarif

PhD Scientist

Johns Hopkins University

Stacey Simmons

Director of Oncology

Bayer AG